Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0024 EUR | 0.00% | -7.69% | -52.94% |
Apr. 19 | European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down | MT |
Apr. 19 | Biophytis Changes ADR Ratio From 100 to 4,000 Shares | MT |
Sales 2024 * | 4.6M 4.9M | Sales 2025 * | 18.2M 19.39M | Capitalization | 2.75M 2.93M |
---|---|---|---|---|---|
Net income 2024 * | -17M -18.11M | Net income 2025 * | -8M -8.52M | EV / Sales 2024 * | 0.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.15 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.58% |
1 week | -7.69% | ||
Current month | -31.43% | ||
1 month | -25.00% | ||
3 months | -52.00% | ||
6 months | -74.74% | ||
Current year | -52.94% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 06-09-14 | |
Nicolas Fellmann
DFI | Director of Finance/CFO | 55 | 23-05-21 |
Claudia Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 23-09-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nadine Coulm
BRD | Director/Board Member | 61 | 15-05-21 |
Claude Allary
BRD | Director/Board Member | 69 | 21-07-06 |
Chief Executive Officer | 58 | 06-09-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.0024 | 0.00% | 12,511,840 |
24-04-18 | 0.0024 | +4.35% | 13,332,410 |
24-04-17 | 0.0023 | -8.00% | 25,683,980 |
24-04-16 | 0.0025 | -3.85% | 29,517,410 |
24-04-15 | 0.0026 | 0.00% | 26,943,420 |
Real-time Euronext Paris, April 19, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-52.94% | 2.93M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- ALBPS Stock